Cargando…

Metabolomic characteristics of cholesterol-induced non-obese nonalcoholic fatty liver disease in mice

Nonalcoholic fatty liver disease (NAFLD) in non-obese patients remains a clinical condition with unclear etiology and pathogenesis. Using a metabolomics approach in a mouse model that recapitulates almost all the characteristic features of non-obese NAFLD, we aimed to advance mechanistic understandi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tu, Lan N., Showalter, Megan R., Cajka, Tomas, Fan, Sili, Pillai, Viju V., Fiehn, Oliver, Selvaraj, Vimal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522413/ https://www.ncbi.nlm.nih.gov/pubmed/28733574 http://dx.doi.org/10.1038/s41598-017-05040-6

Ejemplares similares

Replication Study: The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate
por: Showalter, Megan Reed, et al.
Publicado: (2017)

Inborn Errors of Metabolism in the Era of Untargeted Metabolomics and Lipidomics
por: Ismail, Israa T, et al.
Publicado: (2019)

Generation and quality control of lipidomics data for the alzheimer’s disease neuroimaging initiative cohort
por: Barupal, Dinesh Kumar, et al.
Publicado: (2018)

Erratum: Ismail, I.T.; et al. Inborn Errors of Metabolism in the Era of Untargeted Metabolomics and Lipidomics. Metabolites 2019, 9, 242
por: Ismail, Israa T., et al.
Publicado: (2020)

Short-Term Stability of Serum and Liver Extracts for Untargeted Metabolomics and Lipidomics
por: Hricko, Jiri, et al.
Publicado: (2023)

Profiling of proteins secreted in the bovine oviduct reveals diverse functions of this luminal microenvironment
por: Pillai, Viju Vijayan, et al.
Publicado: (2017)

Obesogenic diets alter metabolism in mice
por: Showalter, Megan R., et al.
Publicado: (2018)

Are Dietary Cholesterol Intake and Serum Cholesterol Levels Related to Nonalcoholic Fatty Liver Disease in Obese Children?
por: Papandreou, Dimitrios, et al.
Publicado: (2012)

Denoising Autoencoder Normalization for Large-Scale Untargeted Metabolomics by Gas Chromatography–Mass Spectrometry
por: Zhang, Ying, et al.
Publicado: (2023)

MS-DIAL: Data Independent MS/MS Deconvolution for Comprehensive Metabolome Analysis
por: Tsugawa, Hiroshi, et al.
Publicado: (2015)

Functional metabolite reserves and lipid homeostasis revealed by the MA-10 Leydig cell metabolome
por: Koganti, Prasanthi P, et al.
Publicado: (2022)

Nutrition and Nonalcoholic Fatty Liver Disease: The Significance of Cholesterol
por: Enjoji, Munechika, et al.
Publicado: (2012)

Remnant cholesterol and severity of nonalcoholic fatty liver disease
por: Huang, Hangkai, et al.
Publicado: (2023)

A metabolome atlas of the aging mouse brain
por: Ding, Jun, et al.
Publicado: (2021)

Metabox: A Toolbox for Metabolomic Data Analysis, Interpretation and Integrative Exploration
por: Wanichthanarak, Kwanjeera, et al.
Publicado: (2017)

Efficient induction and sustenance of pluripotent stem cells from bovine somatic cells
por: Pillai, Viju Vijayan, et al.
Publicado: (2021)

Recent advances in nonalcoholic fatty liver disease metabolomics
por: Kim, Hwi Young
Publicado: (2021)

Untargeted Metabolomics Analysis of the Serum Metabolic Signature of Childhood Obesity
por: Szczerbinski, Lukasz, et al.
Publicado: (2022)

Non-HDL cholesterol and LDL cholesterol in the dyslipidemic classification in patients with nonalcoholic fatty liver disease
por: Du, Tingting, et al.
Publicado: (2017)

Clinical characteristics and risk factors of nonalcoholic fatty liver disease in children with obesity
por: Peng, Luting, et al.
Publicado: (2021)

Association of remnant cholesterol with nonalcoholic fatty liver disease: a general population-based study
por: Zou, Yang, et al.
Publicado: (2021)

Physiological profile of undifferentiated bovine blastocyst-derived trophoblasts
por: Pillai, Viju Vijayan, et al.
Publicado: (2019)

Comparison of Clinical Characteristics Between Obese and Non-Obese Patients with Nonalcoholic Fatty Liver Disease (NAFLD)
por: Li, Yifang, et al.
Publicado: (2021)

L‐arginine as a potential GLP‐1‐mediated immunomodulator of Th17‐related cytokines in people with obesity and asthma
por: Liao, Shu‐Yi, et al.
Publicado: (2021)

Registered report: The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate
por: Fiehn, Oliver, et al.
Publicado: (2016)

Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis
por: Lee, Na Young, et al.
Publicado: (2021)

Serum metabolomic analysis of the effect of exercise on nonalcoholic fatty liver disease
por: Li, Jia, et al.
Publicado: (2019)

Serum metabolome alterations in patients with early nonalcoholic fatty liver disease
por: Wang, Xuemei, et al.
Publicado: (2022)

Serum and urinary metabolomics and outcomes in cirrhosis
por: Bajaj, Jasmohan S., et al.
Publicado: (2019)

Exploring the Impact of Organic Solvent Quality and Unusual Adduct Formation during LC-MS-Based Lipidomic Profiling
por: Cajka, Tomas, et al.
Publicado: (2023)

Obesity and nonalcoholic fatty liver disease: current perspectives
por: Sarwar, Raiya, et al.
Publicado: (2018)

Identifying epimetabolites by integrating metabolome databases with mass spectrometry cheminformatics
por: Lai, Zijuan, et al.
Publicado: (2017)

Comparison between obese and non-obese nonalcoholic fatty liver disease
por: Chan, Wah-Kheong
Publicado: (2023)

PAR2 controls cholesterol homeostasis and lipid metabolism in nonalcoholic fatty liver disease
por: Rana, Rajashree, et al.
Publicado: (2019)

Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanism and Application of Metabolomics
por: He, Xuyun, et al.
Publicado: (2016)

Metabolomics Characterizes the Effects and Mechanisms of Quercetin in Nonalcoholic Fatty Liver Disease Development
por: Xu, Yan, et al.
Publicado: (2019)

Comparison of clinical characteristics between lean and obese nonalcoholic fatty liver disease in the northeast Chinese population
por: Li, Hui, et al.
Publicado: (2019)

Total cholesterol to high-density lipoprotein cholesterol ratio is a significant predictor of nonalcoholic fatty liver: Jinchang cohort study
por: Ren, Xiao Yu, et al.
Publicado: (2019)

Nonalcoholic fatty liver disease in obese and nonobese pediatric patients
por: Kim, Eun Jeong, et al.
Publicado: (2019)

Ezetimibe: Its Novel Effects on the Prevention and the Treatment of Cholesterol Gallstones and Nonalcoholic Fatty Liver Disease
por: de Bari, Ornella, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_u5ne6iehrqctdl9ua8q9clh5dq